Building ‘Mission Essential Infrastructure’ for COVID-19 Response
US Biocontainment Manufacturer Delivers Mobile Unit for Work on Coronavirus Vaccine ORMOND BEACH, Fla. and LOUISVILLE, Ky., April 9, 2020 /PRNewswire/ — This week, Germfree delivered a 53-foot containment cleanroom trailer to a major US pharmaceutical company where they will work on a COVID-19 vaccine. This is the first, of what is expected to be, many mobile laboratory spaces that will be delivered to scientists and organizations working on virus and antibody testing, vaccine development, research, and deployment solutions. Germfree was quickly able to meet the need for a biocontainment unit specifically designed for COVID-19 vaccine development because the company has decades of experience providing rapidly deployable biocontainment laboratory space. Since the 1990s, the Germfree has pioneered the use of mobile containment cleanrooms for surge capacity, hospital renovations, and emergency preparedness. In recent years, the company has deployed over 60 mobile solutions like the ones needed to meet the COVID-19 crisis to public and private healthcare systems across the US, including to the National Institutes of Health (NIH), Massachusetts General Hospital, Stanford Health Care, Kaiser Permanente, UW Medicine, Yale New Haven Health, and the US Department of Veterans Affairs (VA). This experience positions Germfree to provide what is needed today […]
Bio-containment Labs Deployed to Fortify Capacity for Pandemic Response
Ormond Beach, FL, US – April 1st, 2020 – By mid-March, the emerging pandemic sounded alarms at the highest levels and Germfree was being asked to provide biological containment laboratories – fast. Calls came in from public health labs and researchers across the globe who work to contain local outbreaks and prevent regional epidemics. Now facing a pandemic, priorities shifted, and efforts intensified as did the need for bio-containment space. The global response to COVID-19 would reveal critical deficiencies in global laboratory capacity that now require fast, flexible solutions. “COVID-19 presents unprecedented challenges to our global laboratory infrastructure,” said Dr. Steven Jones, Associate Provost for Health Sciences at the University of Saskatchewan and co-discoverer of a vaccine for Ebola. Jones has confronted these concerns with previous coronavirus outbreaks. “Our laboratory capabilities must be agile and responsive to potential biological threats in a wide range of scenarios. In 2014, I worked with Germfree to quickly deploy one of their laboratories to the Middle East to deal with MERS, which was very similar to the current pandemic virus.” Germfree-built facilities are in operation across the world, from resource-challenged regions to modern cities, including a high containment lab in Singapore at the forefront […]
bioGO BSL-3 Mobile Biocontainment Laboratory
Mobile Biocontainment Laboratory, facilities are able to rapidly increase their volume without sacrificing capabilities. Each mobile facility is engineered and constructed to meet or exceed the CDC NIH BMBL guidelines and the World Health Organization (WHO) guidelines for BSL-3 laboratories.